You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BKM120

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Endometrial Cancer, Recurrent Ovarian Cancer Trial (BKM120, Nabpaclitaxel)

Withdrawn
  • Ovarian Cancer
  • +3 more
  • (no location specified)
Jul 27, 2022

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,

Completed
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +8 more
  • PI3K inhibitor BKM120
  • +3 more
  • Atlanta, Georgia
  • +1 more
Jun 27, 2022

Brain Metastases, Breast Cancer, Metastatic Breast Cancer Trial in Multiple Locations (BKM120, capecitabine, Trastuzumab)

Completed
Has Results
  • Brain Metastases
  • +2 more
  • BKM120
  • +2 more
  • Multiple Locations, Texas
    Please contact Zuzanne Bristow for list of sites
Jan 31, 2022

Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer Trial in

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • +5 more
  • BKM120
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 24, 2022

Esophageal Cancer Trial in Hat yai (BKM120)

Terminated
  • Esophageal Cancer
  • BKM120
  • Hat yai, Songkhla, Thailand
    Songklanagarind Hospital, Prince of Songkla University
Oct 3, 2021

High Risk Prostate Cancer Trial in San Francisco (BKM120)

Terminated
Has Results
  • High Risk Prostate Cancer
  • BKM120
  • San Francisco, California
    University of California, San Francisco
Jan 7, 2021

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Advanced Solid Tumor Trial in Nagoya-city, Kashiwa (BKM120)

Completed
  • Advanced Solid Tumor
  • BKM120
  • Nagoya-city, Aichi, Japan
  • +1 more
Dec 6, 2020

Hepatic Impairment Trial in Sofia, Berlin, Moscow (BKM120)

Completed
  • Hepatic Impairment
  • BKM120
  • Sofia, Bulgaria
  • +2 more
Dec 6, 2020

Advanced Breast Cancer, Advanced Carcinomas With Squamous Cell Histology Trial in Guangzhou, Beijing (BKM120)

Completed
  • Advanced Breast Cancer, Advanced Carcinomas With Squamous Cell Histology
  • BKM120
  • Guangzhou, Guangdong, China
  • +2 more
Dec 6, 2020

Ovarian Cancer, Breast Cancer Trial in Boston, New York, Houston (BKM120 and Olaparib, BYL719 and Olaparib)

Completed
  • Ovarian Cancer
  • Breast Cancer
  • BKM120 and Olaparib
  • BYL719 and Olaparib
  • Boston, Massachusetts
  • +4 more
Feb 8, 2021

Glioblastoma Trial in Worldwide (BKM120 + temozolomide, BKM120 +temozolomide with/without radiotherapy)

Completed
  • Glioblastoma
  • BKM120 + temozolomide
  • BKM120 +temozolomide with/without radiotherapy
  • Fayetteville, Arkansas
  • +7 more
Dec 6, 2020

Metastatic or Locally Advanced Solid Tumors Trial in Worldwide (BEZ235 + paclitaxel, BKM120 + paclitaxel, BEZ235 + paclitaxel +

Completed
  • Metastatic or Locally Advanced Solid Tumors
  • BEZ235 + paclitaxel
  • +3 more
  • Bruxelles, Belgium
  • +9 more
Dec 6, 2020

Castration-resistant Prostate Cancer Trial in Worldwide (BEZ235, BKM120)

Completed
  • Castration-resistant Prostate Cancer
  • Los Angeles, California
  • +9 more
Dec 6, 2020

Breast Cancer, Colon Cancer, Ovarian Cancer Trial in Worldwide (BKM120)

Completed
  • Breast Cancer
  • +3 more
  • BKM120
  • Nashville, Tennessee
  • +4 more
Dec 6, 2020

Locally Advanced Solid Tumor Trial in United States (AN2025, AN0025, Atezolizumab 1200 mg in 20 ML Injection)

Recruiting
  • Locally Advanced Solid Tumor
  • Aurora, Colorado
  • +3 more
Feb 16, 2022

Breast Cancer Trial in Spain, United States (BKM120)

Completed
Has Results
  • Breast Cancer
  • BKM120
  • Boston, Massachusetts
  • +6 more
Oct 6, 2020

Metastatic Breast Cancer Trial in Chapel Hill, Durham (BMK120, Capecitabine, BYL719)

Completed
  • Metastatic Breast Cancer
  • Chapel Hill, North Carolina
  • +1 more
Aug 24, 2020

BRAF Mutant Metastatic Melanoma Trial in San Francisco (BKM120 Combined with Vemurafenib (PLX4032))

Completed
Has Results
  • BRAF Mutant Metastatic Melanoma
  • BKM120 Combined with Vemurafenib (PLX4032)
  • San Francisco, California
    University of California, San Francisco
Aug 6, 2020

Advanced and Selected Solid Tumors Trial in Worldwide (BKM120, GSK1120212)

Completed
  • Advanced and Selected Solid Tumors
  • Los Angeles, California
  • +6 more
Dec 6, 2020

3rd Line GIST Trial in Worldwide (STI571, BKM120)

Completed
  • 3rd Line GIST
  • Boston, Massachusetts
  • +10 more
Dec 17, 2020

Breast Cancer Trial in Worldwide (LEE011, BYL719, fulvestrant)

Completed
  • Breast Cancer
  • Birmingham, Alabama
  • +10 more
Dec 16, 2020

Myelofibrosis Trial in Worldwide (INC424, BKM120)

Terminated
  • Myelofibrosis
  • Herston, Queensland, Australia
  • +14 more
Dec 16, 2020

Advanced Solid Tumors, Selected Solid Tumors Trial in Worldwide (BKM120 + MEK162)

Completed
  • Advanced Solid Tumors
  • Selected Solid Tumors
  • BKM120 + MEK162
  • Boston, Massachusetts
  • +11 more
Sep 30, 2020

Glioblastoma Multiforme Trial in United States (Bevacizumab, BKM120)

Completed
Has Results
  • Glioblastoma Multiforme
  • New Haven, Connecticut
  • +7 more
Jun 8, 2020